Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 8(63), 2019
DOI: 10.1128/aac.00060-19
Links
Tools
Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults
Journal article published in 2019 by
Borimas Hanboonkunupakarn,
Rob W. van der Pluijm,
Richard Hoglund,
Sasithon Pukrittayakamee,
Markus Winterberg,
Mavuto Mukaka,
Naomi Waithira 
,
Kesinee Chotivanich,
Pratap Singhasivanon,
Nicholas J. White,
Arjen M. Dondorp,
Joel Tarning ,
Podjanee Jittamala
,
Kesinee Chotivanich,
Pratap Singhasivanon,
Nicholas J. White,
Arjen M. Dondorp,
Joel Tarning ,
Podjanee Jittamala
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 
Abstract
Artemisinin-based combination therapies (ACTs) have contributed substantially to the global decline in Plasmodium falciparum morbidity and mortality, but resistance to artemisinins and their partner drugs is increasing in Southeast Asia, threatening malaria control. New antimalarial compounds will not be generally available soon.